Background: Patients with rheumatoid arthritis (RA) treated with Janus kinase inhibitors (JAKi) have an increased risk of herpes zoster (HZ). A non‑live, recombinant subunit vaccine (Shingrix) offers protection in adults aged ≥50 years, but its …
Background: Pulmonary manifestations contribute significantly to morbidity and mortality in rheumatoid arthritis (RA), yet biomarkers to identify patients at risk of lung involvement are lacking. Objective: To compare proteomic signatures in …